FDA approves drug, diagnostic test for melanoma

Genentech's Zelboraf approved for melanoma with BRAF V600E gene mutation

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug and companion diagnostic test for the most dangerous type of skin cancer, the agency said Wednesday.

The FDA announced the approval of Genentech's and Daiichi Sankyo's Zelboraf (vemurafenib), for patients with late-stage melanoma that can't be removed by surgery. Genentech is the U.S. division of Swiss drug maker Roche.

The drug is approved for patients whose melanoma includes a gene mutation called BRAF V600E, and the drug has not been tested in patients whose tumors don't express the gene. As such, the drug is being approved alongside a test called the cobas 4800 BRAF V600 mutation test, a diagnostic test designed to determine whether a patient's melanoma cells have the mutation.

"This has been an important year for patients with late-stage melanoma," FDA Office of Oncology Drug Products director Richard Pazdur said. "Zelboraf is the second new cancer drug approved that demonstrates an improvement in overall survival."


- 9:39 AM
dietfood says

vitamin D and melanoma - The rapid increase in melanoma incidence and mortality has given rise to nationwide and international campaigns that encourage the public to protect themselves from solar radiation with clothing, sunscreens, and other measures. www.1wallmart.com/category.php?id_category=21 the basis of these campaigns has been challenged by proponents of the theory that vitamin D, which is generated in the skin by ultraviolet B radiation, inhibits tile development of melanoma. The present investigation tests this theory by examining the relation between dietary vitamin D and melanoma risk in a case-control study. Vitamin D intake was assessed by a food-frequency questionnaire in 165 melanoma patients and 209 controls, After controlling for age, hair Color, and family history of melanoma, there was no association of melanoma risk with total vitamin D intake, caloric-adjusted vitamin D intake, vitamin D intake from foods, or consumption of milk or vitamin D supplements. www.cleansemart.com We find no evidence to suggest that vitamin D protects against melanoma, and therefore continue to support the ongoing public health campaigns aimed at reducing sun exposure for the prevention of melanoma.

Login or Register to post a comment.